Hypotension in pregnant women: A population-based case-control study of pregnancy complications and birth outcomes

Hypertension Research

Volumn 34, Issue 1, 2011, Pages 55-61

  Bánhidy, Ferenc ^a   Ács, Nándor ^a   Puhó, Erzsébet H ^b   Czeizel, Andrew E ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

congenital abnormalities; hypotension; hypotension drugs; pregnancy; pregnancy complications

Indexed keywords

EPHEDRINE; FOLIC ACID; PHOLEDRINE;

ADULT; ARTICLE; CHRONIC MATERNAL HYPOTENSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; FETOTOXICITY; HUMAN; HYPOTENSION; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL HYPOTENSION; MEDICAL RECORD; NAUSEA; NEWBORN; POPULATION BASED CASE CONTROL STUDY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PROGENY; PROSPECTIVE STUDY; TERATOGENICITY; VITAMIN SUPPLEMENTATION; VOMITING;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPOTENSION; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK;

EID: 78650856541     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.172     Document Type: Article

References (32)

1. Roberts JM. Pregnancy-related hypertension. In Creasy RK, Resnik R, Iams JD (eds), Maternal-Fetal Medicine. Principles and Practice, 5th edn. Saunders: Philadelphia, 2004, pp 859-899.
2. Churchill D. The new American guidelines on the hypertensive disorders of pregnancy. J Hum Hypertens 2001; 15: 583-585.
3. Gifford R, August P, Cunningham G, Lindheimer MD, McNellis D, Roberts JM, Sibai BM, Taler SJ. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-15.
4. Creasy RK, Resnik R, Iams JD (eds). Maternal-Fetal Medicine. Principles and Practice, 5th edn. Saunders: Philadelphia, 2004.
5. Shepard TH, Lemire RJ. Catalog of Teratogenic Agents, 11th edn. Johns Hopkins University Press: Baltimore, 2004.
6. Czeizel AE, Rockenbauer M, Siffel C, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Te r a -tology 2001; 63: 176-185.
7. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997; 55: 299-305.
8. Czeizel AE, Intody ZS, Modell B. What proportion of congenital abnormalities can be prevented? Br Med J 1993; 306: 499-503.
9. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety 2003; 2: 409-416.
10. Czeizel AE, Vargha P. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 2004; 191: 790-794.
11. Rashidi A, Rachman M, Wright JT. Diagnosis and treatment of hypertension. In: Fuster V, Walsh RA, O'Rourke RA, Poole-Wilson P (eds). Hurst's The Heart, 12th edn. McGraw Hill Medical: New York, NY, 2008, pp 1610-1629.
12. Puho E, Métneki J, Czeizel AE. Maternal employment status and isolated orofacial clefts in Hungary. Cent Eur J Publ Health 2005; 13: 144-148. (Pubitemid 41375082)
13. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 1991; 338: 131-137.
14. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-1835.
15. Berry RJ, Li Z, Erickson JD, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, Hong SX, Correa A. Prevention of neural tube defects with folic acid in China. China-US Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341: 1485-1490.
16. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996; 62: 179-183.
17. Czeizel AE, Dobo M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows reduction in certain congenital abnormalities. Birth Defects Res (Part A) 2004; 70: 853-861.
18. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet Part C 2004; 125C: 12-21.
19. Czeizel AE. Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Defects Res (Part A) 2009; 85: 260-268.
20. McAnulty JH, Brober CS, Metcalfe J. Heart disease and pregnancy. In: Fuster V, Walsh RA, O'Rourke RA, Poole-Wilson P (eds). Hurst's The Heart, 12th edn. McGraw Hill Medical: New York, etc, 2008, pp 2188-2202.
21. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JH. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypert Pregnancy 2001; 20: ix-xiv.
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ, National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, national High Blood Pressure Education Program Coordinating of Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572. (Pubitemid 37430158)
23. Czeizel AE, Puho E, Acs N, Banhidy F. Inverse association between severe nausea and vomiting in pregnancy and some congenital abnormalities. Am J Med Genet 2006; 140A: 453-462.
24. Koch KL. Approach to the patient with nausea and vomiting. In: Yamada T (ed). Textbook of Gastroenterology, 2nd edn. Lippincott JB: Philadelphia, 1955, pp 731-740.
25. Jamfelt-Samsioe A. Nausea and vomiting in pregnancy: A review. Obstet Gynecol Surg 1987; 42E: 422-431.
26. Weakley FL. Anal and perinatal lesions. In: Farmer RG, Achkar E, Fleshler B (eds). Clinical Gastroenterology. Raven Press: New York, 1983, pp 401-407.
27. Resnik R, Creasy RK. Intrauterine growth restriction. In: Creasy RK, Resnik R, IamsJD (eds). Mate rna l-Fetal Medicine. Principles and Practice, 5th edn. Saunders: Philadelphia, 2004, pp 495-512.
28. Lunell NO, Nyland L. Uteroplacental blood flow. Clin Obstet Gynecol 1992; 35: 108-113.
29. Banhidy F, Acs N, Puho HE, Czeizel AE. Teratogenic potential of pholedrine, a sympathomimetic vasoconstrictive drug-a population-based case-control study. Cong Anom 2010; 50: 122-128.
30. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. John Wright Publishing Sciences Group: Littleton, MA, 1977, pp 345-356.
31. Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology 1992; 45: 361-367.
32. Czeizel AE, Petik D, Puho E. Smoking and alcohol drinking during pregnancy. The reliability of retrospective maternal self-reported information. Cent Eur J Publ Hlth 2004; 12: 179-183.